OPRM1 and breast cancer: By contrast, opioids promoted the growth of MCF-7 breast cancer cells, which was blocked with the mu-opioid receptor antagonist naloxone, and naltrexone promoted apoptosis in a mouse model of MCF-7 cells and decreased the growth of the triple-negative breast cancer MDA-MB-231 cell line [147,291,292].